Yayın:
P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorÜskent, Necdet
dc.contributor.authorNuri Karadurmuş
dc.contributor.authorTaner Korkmaz
dc.contributor.authorPerran Fulden Yumuk
dc.contributor.authorİ. Çiçin
dc.contributor.authorSemra Paydaş
dc.contributor.authorEbru Çılbır
dc.contributor.authorTeoman Şakalar
dc.contributor.authorMükremın Uysal
dc.contributor.authorNecdet Üskent
dc.contributor.authorNazan Demir
dc.contributor.authorAbdullah Sakin
dc.contributor.authorN. S. Turhal
dc.contributor.authorSerkan Keskın
dc.contributor.authorDeniz Tural
dc.contributor.authorYeşim Eralp
dc.contributor.authorFatma Buğdaycı Başal
dc.contributor.authorArzu Yaşar
dc.contributor.authorMehmet Alı Nahıt Şendur
dc.contributor.authorUmut Demırcı
dc.contributor.authorErdem Çubukçu
dc.contributor.authorMustafa Karaağaç
dc.contributor.authorBurçak Karaca
dc.contributor.authorAli Murat Tatlı
dc.contributor.authorTarkan Yetişyiğit
dc.contributor.authorSemiha Urvay
dc.contributor.authorPınar Gürsoy
dc.contributor.authorBaşak Oyan Uluç
dc.contributor.authorHande Turna
dc.contributor.authorMehmet Küçüköner
dc.contributor.authorÖmer Fatih Ölmez
dc.contributor.authorDevrim Çabuk
dc.contributor.authorMesut Şeker
dc.contributor.authorÖzkan Ünal
dc.contributor.authorNezih Meydan
dc.contributor.authorSadi Kerem Okutur
dc.contributor.authorDidem Tunalı
dc.contributor.orcid0000-0003-1637-7390
dc.contributor.orcid0000-0002-3445-3804
dc.contributor.orcid0000-0003-3291-8062
dc.contributor.orcid0000-0003-4292-0545
dc.contributor.orcid0000-0001-8650-299X
dc.contributor.orcid0000-0003-4642-3693
dc.contributor.orcid0000-0003-2749-9414
dc.contributor.orcid0000-0002-8524-0665
dc.contributor.orcid0000-0003-2739-7362
dc.contributor.orcid0009-0000-2988-4450
dc.contributor.orcid0000-0003-2538-8569
dc.contributor.orcid0000-0002-1013-5676
dc.contributor.orcid0000-0002-4017-7447
dc.contributor.orcid0000-0003-2144-6469
dc.contributor.orcid0000-0001-9603-4755
dc.contributor.orcid0000-0002-0545-1383
dc.contributor.orcid0000-0001-7021-6139
dc.contributor.orcid0000-0002-4833-6721
dc.contributor.orcid0000-0002-0070-0889
dc.contributor.orcid0000-0003-4533-0620
dc.contributor.orcid0000-0003-2638-1625
dc.contributor.orcid0000-0001-9696-1102
dc.contributor.orcid0000-0002-4622-4742
dc.contributor.orcid0000-0002-0181-3842
dc.contributor.orcid0000-0003-1392-6753
dc.contributor.orcid0000-0002-6623-6273
dc.contributor.orcid0000-0003-0558-9371
dc.contributor.orcid0000-0001-7336-871X
dc.contributor.orcid0000-0001-7934-7039
dc.contributor.orcid0000-0002-7871-6311
dc.contributor.orcid0000-0002-3721-5406
dc.contributor.orcid0000-0001-5024-8918
dc.contributor.orcid0000-0003-4100-5804
dc.contributor.orcid0000-0003-1064-3707
dc.date.accessioned2025-11-13T22:57:39Z
dc.date.issued2018-10-01
dc.identifier.doihttps://doi.org/10.1016/j.jtho.2018.08.601
dc.identifier.endpageS478
dc.identifier.issn1556-0864
dc.identifier.issue10
dc.identifier.openalexW2898138407
dc.identifier.startpageS477
dc.identifier.urihttps://hdl.handle.net/11421/15879
dc.identifier.urihttps://doi.org/10.1016/j.jtho.2018.08.601
dc.identifier.volume13
dc.language.isoen
dc.relation.ispartofJournal of Thoracic Oncology
dc.rightsopenAccess
dc.subjectCrizotinib
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectLung cancer
dc.subjectStage (stratigraphy)
dc.subjectALK inhibitor
dc.subjectAdenocarcinoma
dc.subjectMedical record
dc.subjectOncology
dc.subjectGastroenterology
dc.subjectCancer
dc.titleP1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743
local.authorid.openalexA5064757657

Dosyalar

Koleksiyonlar

Publications